|
University of Maryland School of Medicine orders AVANCE III 950 US2 NMR spectrometer from Bruker
Bruker Corporation announces a major order from the University of Maryland School of Medicine for its ultra-high field AVANCE III 950 US2 NMR spectrometer. The 950 MHz Nuclear Magnetic Resonance magnet and spectrometer will help University of Maryland researchers to unravel the mysteries of molecules and develop new agents to treat cancer, AIDS and other diseases.
www.news-medical.net
Reportlinker Adds Neuroprotection - Drugs, Markets and Companies
Reportlinker.com announces that a new market research report is available in its catalogue:
biz.yahoo.com
Reportlinker Adds Cardiovascular Drug Delivery - Technologies, Markets and Companies
NEW YORK , Sept. 7 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Cardiovascular Drug Delivery - technologies, markets and companies http://www.reportlinker.com/p0203538/Cardiovascular-Drug-Delivery---technologiesmarkets-and-companies.html Summary Drug delivery to the cardiovascular system is different from ...
biz.yahoo.com
Researcher awarded $1.8M grant to investigate sex differences in anxiety
Anxiety disorders afflict women twice as often as men, but estrogen might not be the reason. Testosterone, though, could be. That is one of the preliminary findings in the lab of Florida State University researcher Mohamed Kabbaj, associate professor in the College of Medicine. He recently was awarded a five-year, $1.8 million grant from the National Institute of Mental Health to investigate the ...
www.news-medical.net
Results From Investigator-Sponsored Trials Presented at SSIEM Conference
NOVATO, Calif., Sept. 1 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that results from investigator-sponsored studies on Kuvan (sapropterin dihydrochloride) are being presented at the 2010 Annual Symposium of the Society for The Study of Inborn Errors of Metabolism (SSIEM), August 31st-September 3rd in Istanbul, Turkey. Investigators reported that PKU ...
www.redorbit.com
Success story: Pain treatments made easy
Brad Welch never thought he'd see a chiropractor.
www.news-press.com
Fidelity Biosciences Joins $20M Series C for ViewRay
Aisling Capital ViewRayTM, Inc., a privately held medical device company, has secured $20 million in...
boston.citybizlist.com
ViewRay Secures Series C Financing
ViewRayâ¢, Inc., a privately held medical device company, has secured $20 million in Series C financing led by new investor Siemens Venture Capital GmbH and joined by existing investors Aisling Capital, Fidelity Biosciences, Kearny Venture Partners and OrbiMed Advisors.
biz.yahoo.com
Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease
Genzyme Corporation announced today that the two-year follow-up results from the phase 2 clinical trial of its investigational therapy known as eliglustat tartrate have been accepted for publication in the journal Blood. The results have been pre-published on the journal's website and are available to subscribers.
www.news-medical.net
Diamond Dust Polishes and Shines to Create Luminous Results in Luxurious Signature Treatments at New Coral Beach Gem Spa
Diamonds are widely known for being a girl’s best friend, and at the new world-class Gem Spa at the Fiesta Americana Grand Coral Beach Cancún Resort & Spa, they prove to be a best friend and more by creating luminous, healing results. The recently-opened 40,000 square-foot spa features a signature treatment menu utilizing diamond dust through exfoliation and magnetism, all designed to create ...
news.yahoo.com
|
